Literature DB >> 6227757

Manifestations of coronary disease predisposing to stroke. The Framingham study.

W B Kannel, P A Wolf, J Verter.   

Abstract

Coronary heart disease (CHD) was examined as a precursor of stroke based on 24 years of biennial examinations, during which time 344 strokes occurred. Routine ECGs, chest roentgenograms, and BP levels were obtained, CHD and cardiac failure status were evaluated at each examination, and risk of stroke was ascertained. The five major CHD risk factors jointly were actually as predictive of stroke as CHD. The dominant stroke risk factors were hypertension, clinical manifestations of CHD, cardiac failure, atrial fibrillation, and ECG and roentgenographic evidence of a compromised coronary circulation. Coronary heart disease almost tripled the risk of a stroke, and cardiac failure was associated with more than a fivefold increased risk. Angina pectoris carried half the risk of myocardial infarction. Coronary disease and cardiac failure added to the risk of stroke associated with hypertension. Coronary heart disease increased stroke risk in the absence of hypertension or cardiac failure, but risk was greatly augmented when these coexisted.

Entities:  

Mesh:

Year:  1983        PMID: 6227757

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  30 in total

1.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

Review 2.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

3.  The quality of diabetes care following hospitalization for ischemic stroke.

Authors:  Nancy Pandhi; Maureen A Smith; Amy J H Kind; Jennifer R Frytak; Michael D Finch
Journal:  Cerebrovasc Dis       Date:  2009-01-29       Impact factor: 2.762

4.  Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.

Authors:  Shunichi Homma; Siqin Ye
Journal:  Circulation       Date:  2015-03-25       Impact factor: 29.690

5.  Secondary prevention after ischemic stroke. Evolution over time in practice.

Authors:  Marie Girot; Marie-Anne Mackowiak-Cordoliani; Dominique Deplanque; Hilde Hénon; Christian Lucas; Didier Leys
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Noninvasive assessment of stroke risk in asymptomatic and nonhemispheric patients with suspected carotid disease. Five-year follow-up of 294 unoperated and 81 operated patients.

Authors:  D J Moore; R D Miles; N A Gooley; D S Sumner
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

7.  Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

8.  Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.

Authors:  Antonio Coca; Franz H Messerli; Athanase Benetos; Qian Zhou; Annette Champion; Rhonda M Cooper-DeHoff; Carl J Pepine
Journal:  Stroke       Date:  2007-12-27       Impact factor: 7.914

Review 9.  The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

Authors:  Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Journal:  J Cardiovasc Transl Res       Date:  2012-12-04       Impact factor: 4.132

10.  Postmenopausal oestrogen treatment and stroke: a prospective study.

Authors:  A Paganini-Hill; R K Ross; B E Henderson
Journal:  BMJ       Date:  1988 Aug 20-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.